• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Illumina expects EU order to keep Grail a separate company

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

The company is likely to face other measures on top of the hold separate order, however, with the EU competition enforcer sending a warning to other companies.

Illumina finalised the Grail takeover last month and said it would hold the company separate while waiting for a European Commission decision on the deal, defying EU merger rules against gun-jumping.

Previous instances of gun-jumping have resulted in companies being hit with million-euro fines. Sanctions can be as much as 10% of a company’s global turnover.

“We had anticipated that the Commission would seek to impose a hold separate order, and this is the reason why it has already voluntarily agreed to such an arrangement; their proposals are based on Illumina’s voluntary undertakings,” Illumina said in a statement.

It said it would discuss certain changes suggested by the EU in the coming days.

The EU competition enforcer earlier on Monday said it had sent a statement of objections or charge sheet to the companies, setting out the interim measures it plans to take. It did not provide details.

Under EU merger rules, the competition watchdog can order companies to unwind their deals or sell off shares or assets acquired for violations.

Commission Vice-President Margrethe Vestager underlined the seriousness of Illumina’s actions, saying it was the first time companies had openly implemented a deal while regulators were still investigating.

“The standstill obligation is a cornerstone of our ex-ante merger control regime which aims at preventing harmful effects to competition while our review is ongoing,” she said in a statement.

The Commission said the interim measures aim to restore and maintain effective competition pending a final decision on the deal.

The Commission will make a final decision on the measures after receiving the companies’ response.

(Reporting by Foo Yun Chee in BrusselsEditing by Jan Harvey and Matthew Lewis)

Source Link Illumina expects EU order to keep Grail a separate company

David Barret
David Barret

Related posts:

  1. Lebanon agrees new government to tackle economic collapse
  2. India, Australia eye closer security ties as 9/11 anniversary marked
  3. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  4. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • First X-Ray Image Of Comet 3I/ATLAS Reveals Signature Unseen In Other Interstellar Objects
  • The Surprisingly Scientific Events That Occurred On Christmas Day
  • Humans Are The Smartest And Dumbest Animal Of All Time, Argues Biologist
  • The Final Secret Of Self-Healing Roman Concrete May Have Been Cracked
  • People Are Confused By The Natural Markings On Watermelons That Look Like “Crop Circles”
  • Pica: The Disorder That Makes People Crave And Eat The Inedible
  • Project Alpha: In 1979, Magicians Infiltrated A Washington Laboratory To Test Scientific Rigor In Parapsychology
  • We May Finally Know What Caused The “Hobbit” Humans To Go Extinct
  • Radical New Treatment Clears Disease In 64 Percent Of Patients With Incurable Cancer
  • People Are Just Now Realizing That The Earth Has A Tail, Stretching At Least 2 Million Kilometers
  • Where On Earth Does Cinnamon Come From?
  • Born With No Feet, Andy The Goose Got Second-Chance Sneakers – But Murder Was Afoot
  • Where Does Pepper Come From?
  • 30-Cargo-300: Major Report Outlines The Priorities For A NASA-Led Human Mission To Mars
  • Like Cheesy Vomit: Why Does American Chocolate Taste So Weird To Europeans?
  • First Treasure From The “$17-Billion-Dollar” Gold-Laden Shipwreck Has Been Recovered
  • Never-Before-Seen Strain Of Mpox Virus Identified In England
  • “Starved To Death En Masse”: Populations Of Breeding Penguins Fall 95 Percent In Just A Few Years
  • Never-Before-Seen Black Hole Blast Clocked At Record-Breaking 60,000 Kilometers Per Second
  • Does This Ancient Egyptian Scroll Recount The World’s Oldest Magic Trick?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version